{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:17:00Z","timestamp":1784092620209,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.radonc.2024.110119","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T23:53:32Z","timestamp":1706918012000},"page":"110119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9617-7040","authenticated-orcid":false,"given":"Mihir D.","family":"Shanker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana P.","family":"Cavazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-6996","authenticated-orcid":false,"given":"Thomas H.","family":"Beckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra N.","family":"Yeboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Frances","family":"McAleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5829-3991","authenticated-orcid":false,"given":"Tina Marie","family":"Briere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-3466","authenticated-orcid":false,"given":"Behrang","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio E.","family":"Tatsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-5595","authenticated-orcid":false,"given":"Robert Y.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Alvarez-Breckenridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip Cem","family":"Cezayirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence D.","family":"Rhines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol J.","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110119_b0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/2017.1.SPINE161045","article-title":"Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations","volume":"27","author":"Bishop","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2024.110119_b0010","series-title":"Radiation Therapy for Sarcomas and Skin Cancers: A Practical Guide on Treatment Techniques","first-page":"77","article-title":"Radiation Therapy for Oligometastatic Sarcomas","author":"Wong","year":"2022"},{"key":"10.1016\/j.radonc.2024.110119_b0015","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","article-title":"Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence","volume":"92","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110119_b0020","first-page":"24","article-title":"Stereotactic radiosurgery for primary and metastatic sarcomas of the spine","volume":"7","author":"Elibe","year":"2018","journal-title":"Appl Rad Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0025","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/cancers12113242","article-title":"Radiation therapy in adult soft tissue sarcoma\u2014current knowledge and future directions: a review and expert opinion","volume":"12","author":"Roeder","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2024.110119_b0030","article-title":"Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature. Clin Transl","author":"Terlizzi","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0035","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820904447","article-title":"Stereotactic body radiation therapy with simultaneous integrated boost in patients with spinal metastases","volume":"19","author":"Pontoriero","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2024.110119_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2019.06.003","article-title":"Low incidence of late failure and toxicity after spine stereotactic radiosurgery: secondary analysis of phase I\/II trials with long-term follow-up","volume":"138","author":"Ning","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0045","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.2147\/CMAR.S186630","article-title":"Single-fraction radiotherapy (SFRT) for bone metastases: patient selection and perspectives","volume":"11","author":"Loi","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.radonc.2024.110119_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5977-6","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4\u201310 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial","volume":"19","author":"Palma","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2024.110119_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3455-6","article-title":"A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)","volume":"17","author":"Radwan","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2024.110119_b0060","doi-asserted-by":"crossref","first-page":"983","DOI":"10.5306\/wjco.v11.i12.983","article-title":"Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study","volume":"11","author":"Mielgo-Rubio","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3171\/2016.1.SPINE151166","article-title":"The use of spine stereotactic radiosurgery for oligometastatic disease","volume":"25","author":"Ho","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2024.110119_b0070","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: A single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bju.15541","article-title":"Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation","volume":"129","author":"De","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2024.110119_b0080","series-title":"Adult CNS radiation oncology: Principles and Practice","author":"Chang","year":"2018"},{"key":"10.1016\/j.radonc.2024.110119_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-020-00936-5","article-title":"The evolving role of radiation therapy in patients with metastatic soft tissue sarcoma","volume":"22","author":"Farooqi","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.radonc.2024.110119_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-023-02226-3","article-title":"Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy","volume":"18","author":"Gutkin","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/927972","article-title":"Radiation therapy for palliation of sarcoma metastases: a unique and uniform hypofractionation experience","volume":"2010","author":"Soyfer","year":"2010","journal-title":"Sarcoma"},{"key":"10.1016\/j.radonc.2024.110119_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101165","article-title":"Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization","volume":"14","author":"Yang","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0105","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.3390\/cancers13194775","article-title":"Radiation therapy in metastatic soft tissue sarcoma: from palliation to ablation","volume":"13","author":"Shah","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2024.110119_b0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PPO.0000000000000551","article-title":"Stereotactic body radiotherapy in oligomestatic\/oligoprogressive sarcoma: safety and effectiveness beyond intrinsic radiosensitivity","volume":"27","author":"Greto","year":"2021","journal-title":"Cancer J"},{"key":"10.1016\/j.radonc.2024.110119_b0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2013.12.042","article-title":"Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine","volume":"88","author":"Folkert","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110119_b0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.prro.2021.07.004","article-title":"A Volumetric Dosimetry Analysis of Vertebral Body Fracture Risk After Single Fraction Spine Stereotactic Body Radiation Therapy","volume":"11","author":"Lee","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0125","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","article-title":"Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases","volume":"27","author":"Rose","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0130","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0135","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/j.ijrobp.2012.04.034","article-title":"Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors","volume":"84","author":"Cunha","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110119_b0140","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2024.110119_b0150","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0155","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3171\/2015.10.SPINE141261","article-title":"Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation","volume":"24","author":"Jawad","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2024.110119_b0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/neuros\/nyx493","article-title":"Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors","volume":"83","author":"Faruqi","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2024.110119_b0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","article-title":"Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT)","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110119_b0170","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2016.10.FOCUS16359","article-title":"Frequency of symptomatic vertebral body compression fractures requiring intervention following single-fraction stereotactic radiosurgery for spinal metastases","volume":"42","author":"Virk","year":"2017","journal-title":"Neurosurg Focus FOC"},{"key":"10.1016\/j.radonc.2024.110119_b0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3171\/2011.11.SPINE116","article-title":"Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases: Clinical article","volume":"16","author":"Boehling","year":"2012","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2024.110119_b0180","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2010.34.3897","article-title":"Spinal Instability Neoplastic Score: An Analysis of Reliability and Validity From the Spine Oncology Study Group","volume":"29","author":"Fourney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0185","article-title":"Radiation Dose-Volume Effects in the Spinal Cord. Int","volume":"76(3, Supplement):S42\u20139","author":"Kirkpatrick","year":"2010","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1\u20133) spine metastases: Phase 2 results","volume":"4","author":"Ryu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110119_b0195","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110119_b0200","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.prro.2021.03.005","article-title":"Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials","volume":"11","author":"Gerhard","year":"2021","journal-title":"Pract Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:28:04Z","timestamp":1759123684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"alternative-id":["S0167814024000409"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110119","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110119"}}